Projects per year
Personal profile
Research interests
Suresh Senan is the Professor of Clinical Experimental Radiotherapy at the Amsterdam University Medical Centers (VUmc location), The Netherlands. He completed training in radiotherapy and oncology in the United Kingdom. His research group is active in lung cancer, use of immune checkpoint inhibitors, magnetic resonance imaging-guided radiotherapy and stereotactic radiotherapy. He is a faculty member for thoracic malignancies at the European Society for Medical Oncology.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
FAST-METS: Evaluation of Fast, Same-day Delivery of Palliative Radiotherapy Without a Planning CT
Nelissen, K., Senan, S., Verbakel, W. & Versteijne, E.
4/01/2021 → 1/01/2024
Project: Research
-
Ontwikkeling keuzehulp vroeg stadium longkanker
Damman, O., Timmermans, D., Hopmans, W., Senan, S. & Becker - Commissaris, A.
1/07/2015 → 31/01/2016
Project: Other
-
Shared Decision Making about treatment for stage 1 non-small cell lung cancer
Damman, O., Hopmans, W., Senan, S. & Timmermans, D.
1/01/2011 → 1/01/2016
Project: Research
-
Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy
Rabe, M., Palacios, M. A., van Sörnsen de Koste, J. R., Eze, C., Hillbrand, M., Belka, C., Landry, G., Senan, S. & Kurz, C., May 2023, In: Medical physics. 50, 5, p. 2625-2636 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer
Dickhoff, C., Unal, S., Heineman, D. J., Winkelman, J. A., Braun, J., Bahce, I., van Dorp, M., Senan, S. & Dahele, M., 1 Aug 2023, In: Lung Cancer. 182, 107294.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy
Tekatli, H., Palacios, M. A., Schneiders, F. L., Haasbeek, C. J. A., Slotman, B. J., Lagerwaard, F. J. & Senan, S., 1 Oct 2023, In: Radiotherapy and oncology. 187, 109823.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Long-Term Outcomes After Chemoradiotherapy and Surgery for Superior Sulcus Tumors
Ünal, S., Winkelman, J. A., Heineman, D. J., Bahce, I., van Dorp, M., Braun, J. A., Hashemi, S., Senan, S., Paul, M. A., Dahele, M. & Dickhoff, C., 1 Apr 2023, In: JTO Clinical and Research Reports. 4, 4, 100475.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Same-day adaptive palliative radiotherapy without prior CT simulation: Early outcomes in the FAST-METS study
Nelissen, K. J., Versteijne, E., Senan, S., Rijksen, B., Admiraal, M., Visser, J., Barink, S., de la Fuente, A. L., Hoffmans, D., Slotman, B. J. & Verbakel, W. F. A. R., 1 May 2023, In: Radiotherapy and oncology. 182, 109538.Research output: Contribution to journal › Article › Academic › peer-review
Open Access3 Citations (Scopus)